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espectively).
Implantable cardioverter defibrillator therapy is a primary
ption for prevention of sudden cardiac death in advanced
ardiomyopathies and CHF (3,4). In the post-LVAD patient,
entricular arrhythmias are associated with a more malignant
ourse both by the frequency and timing of their appearance (5).
his adverse association has theoretically justified the use of
CDs in the setting of LVAD-supported cardiomyopathy, with
ore studies necessary to assess their role in outcomes. As
evice therapy becomes commonplace with more complex
isease, device interactions will need to be factored into the
omplex nature of patient management (6). Careful planning by
he FCC and device manufacturers will play a major role in
heir avoidance.
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f Remote Magnetic
blation for Atrial Fibrillation
e read the recent study by Di Biase et al. (1) published in the
ournal. Our pivotal experience demonstrated that remote
blation is effective and safe without tip charring (2). These
esults were subsequently confirmed in hundreds of patients
ndergoing atrial fibrillation ablation. What is surprising in thisrocedures, the investigators continued to use it, further expos-
ng their patients to the risk of charring and embolic events and
hat the ethics committee further approved the study despite
otentially dangerous complications.
Considering Natale’s extensive experience, he certainly under-
tands that unlike the perpendicular orientation of manual cathe-
ers, the stable parallel wall contact obtained with soft magnetic
atheters results in rapid and effective lesions, within a few seconds
rom the onset of radio frequency (RF) application, thus prevent-
ng charring. However, if abatement of the atrial potentials is not
apidly achieved because the magnetic tip is not completely alignedyopa
nced
ng Fre
lsed co
quenc
‡
ntableith the endocardial wall, continuous and prolonged application of
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April 22, 2008:1613–7igh RF energy, as performed by the investigators (1), could result
n charring and ineffective lesions. No data were reported on
mportant parameters including tip orientation, temperature, RF
nergy, and impedance values before and at the time of charring
ormation. We presume that parameters and potential changes
ere collected throughout, but surprisingly were not reported
recluding any possible interpretation and discussion to explain
hy charring formation and ineffective lesions were so frequent in
heir experience. We know that even a single RF application of long
uration by a soft magnetic catheter requires an accurate and contin-
ous monitoring of all parameters to evaluate potential changes to
revent catheter tip charring. Remote ablation is a novel and simple
ystem, but at the beginning, it may be complex because it is totally
ifferent from the conventional system. Optimization of RF
pplication by this system is crucial and may be challenging at the
eginning, requiring a learning curve. However, once familiarized
ith this system, “effective” remote ablation can be easily per-
ormed. Currently, in our laboratory, “joystick” ablation is per-
ormed by many electrophysiologists after widely different learning
urves. In our pilot study, we specified that remote ablation was
erformed by a single expert operator after his learning curve. How
any of the 20 reported investigators (1) actually performed the
nitial 48 procedures and how many the final ones? It is surprising
hat remote ablation was demonstrated to be safe and effective in
liminating even left-sided accessory pathways and not atrial
otentials. On the other hand, it is well known that prolonged RF
pplications can result in charring even with manual catheters. It
eems that the purpose of that study was to limit the enthusiasm of
reliminary encouraging results of joystick ablation. However, this
ill not delay robotic development because irrigated-tip magnetic
atheters are already available, making remote procedures less
hallenging.
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eply
e thank Drs. Pappone and Santinelli for their interest in our
aper (1).
Overall, our study (1) demonstrated that remote magnetic naviga-
ion is feasible and safe for mapping in the left atrium. Our major
oncern was limited to the use of the 4-mm catheter tip (the only one
vailable at the time of the study) which, in our experience, was unable
o create effective lesions to achieve complete electrical isolation of the *ulmonary vein antrum; in addition, ablation with this catheter was
ssociated with charring in a large number of patients (1).
Regarding the specific questions contained in their letter, our
eply follows.
In the first 48 cases (considered the learning curve), we did not
erform ablation. These cases were used to practice mapping and
avigation in the left atrium and no radiofrequency energy was
elivered.
Two of the 20 authors performed all the procedures in
he learning curve group and subsequently performed the
blation procedures in the 45 patients who were the object of
he study.
As far as the alignment of the catheter tip and the abatement of
he atrial potentials are concerned, it is well established (2) that
eduction of local electrograms does not necessarily reflect the
ransmurality of the lesions. In addition, in our experience, the soft
ip did not appear to increase the ability to position the catheter
arallel to the tissue plane. However, regardless of the catheter
rientation, lesion formation should follow the same biophysical
rinciples. Indeed, previous experimental data show that the time
o steady-state tissue temperature during radiofrequency catheter
blation is approximately 60 to 90 s (3,4).
In the patients undergoing ablation, the duration and maximum
ower were reduced from 60 to 45 s and from 50 to 40 W once
harring was observed. This did not abolish charring, which was
bserved even after a few seconds of energy delivery.
The setting parameters during catheter ablation were clearly
eported in the Methods section. Similarly, we mentioned that to
revent charring, we tried to reduce lesions duration and maximum
ower, and realized, by monitoring with intracardiac echo, which
as not used in the Pappone et al. (5) study, that charring can form
ithin a few seconds and most of the time it is not associated with
ny change in impedance. On average, there was no difference in
elivery settings between lesions with and without charring.
esides direct visualization of the charring with intracardiac echo,
he only indirect clue observed at times was a sudden drop of the
elivered power.
Our results were shared and endorsed in the editorial of Lindsay
6), who appeared to have experienced similar problems. In this
espect, even ablation of left side pathways has been associated
ith a wide range of success (from 67% to 92%) based on the
atheter design (7).
We do not share the conclusions of Drs. Pappone and Santinelli
hat our study “limits the enthusiasm of preliminary encouraging
esults of joystick ablation” with magnetic navigation. We are
nthusiastic about remote catheter ablation. We are currently using
he new 8-mm catheter tip and are waiting for the development of
he irrigated cool tip catheter, because we are sure that it will
mprove the results.
On the other hand, we do not understand why Drs. Pappone
nd Santinelli are so eager to use the new cool tip catheter
onsidering that they had no problems with the standard 4-mm
atheter tip. It is ironic that they consider the irrigated tip catheter
mportant in moving this technology forward.
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